Holen Sie sich die Stockscreener-App
8.71
3.44%
-0.31
Handel nachbörslich:
8.79
0.08
+0.92%
Organon Co Aktie (OGN) Neueste Nachrichten
OGN INVESTIGATION NOTICE: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire
OGN STOCK ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of an Ongoing Investigation - ACCESS Newswire
Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ORGANON ALERT: Bragar Eagel & Squire, P.C. is Investigating Organon & Co. on Behalf of ... - Bluefield Daily Telegraph
ORGANON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Why Investors Shouldn't Be Surprised By Organon & Co.'s (NYSE:OGN) 30% Share Price Plunge - simplywall.st
Levi & Korsinsky Announces an Investigation on Behalf of Organon & Co. (OGN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets - marketscreener.com
Organon: Management Slashes DividendThis Feels Disastrous (NYSE:OGN) - Seeking Alpha
2025-05-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation | NYSE:OGN | Press Release - Stockhouse
Ex-Dividend Reminder: H2O America, Exelon Corp and Organon & Co - Nasdaq
EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug - marketscreener.com
Organon Executives Make Bold Moves with Major Stock Purchases - TipRanks
Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment - simplywall.st
Insider Buying: Aaron Falcione Acquires Shares of Organon & Co (OGN) - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Organon & Co. (OGN) - ACCESS Newswire
Organon & Co. Executives Increase Their Holdings - TradingView
Income Investors Should Know That Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - simplywall.st
Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon - Yahoo Finance
FDA accepts Organon BLA for Prolia/Xgeva biosimilar - MSN
Levi & Korsinsky Reminds Organon & Co. Investors of the Ongoing Investigation into Potential Violations of Securities LawsOGN - ACCESS Newswire
Top Executives Make Bold Moves with Major Organon Stock Purchases! - TipRanks
Organon & Co. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsOGN - PR Newswire
Did Organon & Co. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateOGN - ACCESS Newswire
Organon downgraded to In Line from Outperform at Evercore ISI - MSN
Organon & Co. Executives Make Significant Stock Purchases - TradingView
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon & Co. (NYSE:OGN) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Organon (OGN) Faces Price Target Cut Amid Dividend Adjustment - GuruFocus
Organon & Co. (NYSE:OGN) Given New $10.00 Price Target at Morgan Stanley - Defense World
OGN Stock: Analyst Maintains Rating, Lowers Price Target to $10 | OGN Stock News - GuruFocus
Organon price target lowered to $10 from $15 at Morgan Stanley - TipRanks
OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire
Organon & Co. (NYSE:OGN) Cut to “Inline” at Evercore ISI - Defense World
Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02 - simplywall.st
Organon & Co. (NYSE:OGN) Sets New 52-Week Low – Here’s Why - Defense World
Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Brokerages Set Organon & Co. (NYSE:OGN) Target Price at $19.75 - Defense World
SLQT INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into SelectQuote, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.
OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Organon price target lowered to $10 from $11 at BofA - Yahoo Finance
Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion - MSN
Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (OGN) - Seeking Alpha
Organon & Co. SEC 10-Q Report - TradingView
Evercore ISI Downgrades Organon to In Line From Outperform - marketscreener.com
Organon & Co. Sees Unusually Large Options Volume (NYSE:OGN) - Defense World
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN
Organon & Co. Earnings Call: Growth Amid Challenges - TipRanks
Organon (OGN) Faces Downgrade Following Dividend Reduction | OGN Stock News - GuruFocus
Organon Co earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia
Organon (OGN) Faces Price Target Reduction and Dividend Cut | OG - GuruFocus
OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm - Business Wire
Organon (OGN) Significantly Reduces Quarterly Dividend | OGN Sto - GuruFocus
Organon (OGN) Significantly Reduces Quarterly Dividend | OGN Stock News - GuruFocus
Organon (OGN) Sees Growth in Nexplanon and Strategic Restructuri - GuruFocus
Organon slashes dividend - CNBC
Organon (OGN) Expands Board with New Appointment - GuruFocus
Organon (OGN) Set to Announce Q1 2025 Financial Results - GuruFocus
Organon (OGN) Slashes Quarterly Dividend by 92.9% - GuruFocus
Earnings call transcript: Organon Q1 2025 results show mixed signals By Investing.com - Investing.com India
Earnings call transcript: Organon Q1 2025 results show mixed signals - Investing.com
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):